Stimwave Technologies has announced a partnership with Epimed International.
The partnership, in addition to co-product development, will support distribution of Stimwave’s Wireless Pain Relief technology, expanding the Stimwave USA network to more than 100 sales representatives speaking directly to doctors, medical centres and hospitals across the country. Stimwave’s wireless neuromodulation device became available in the USA in January 2015.
“This is an extremely significant partnership that will dramatically accelerate the introduction of Stimwave’s Wireless Pain Relief technology not only to physicians across the country, but more importantly to the millions of chronic pain patients who will benefit from it,” said Stimwave chairman Laura Tyler Perryman.
The partnership will include Stimwave utilisation of Epimed’s manufacturing, packaging, fulfilment, distribution, reimbursement and physician services.